ANALYSIS OF MURINE ANTIBODY-RESPONSES TO BACULOVIRUS-EXPRESSED HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEINS

被引:8
|
作者
BRISTOW, RGW [1 ]
DOUGLAS, AR [1 ]
SKEHEL, JJ [1 ]
DANIELS, RS [1 ]
机构
[1] NATL INST MED RES, DIV VIROL, LONDON NW7 1AA, ENGLAND
来源
关键词
D O I
10.1099/0022-1317-75-8-2089
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
An analysis of the humoral immunogenicity of a candidate AIDS vaccine (VaxSyn) in a murine model system is presented. Sera taken from a panel of mice immunized with the immunogen were analysed for their ability to bind a panel of gp120-representing peptides and limited reactivity to known sites of immunological interest was observed. Monoclonal antibodies (MAbs) were characterized as binding to a more restricted variety of regions on gp 120 including C1, V2, V4 and the C terminus. A tetrazolium-based cytocidicity assay was used and shown to be an effective and objective method for the screening of human immunodeficiency virus (HIV)-neutralizing activity in large numbers of samples. None of the MAbs characterized in this study neutralize HIV-1 reference strains. The significance of these findings in view of previous publications is discussed.
引用
收藏
页码:2089 / 2095
页数:7
相关论文
共 50 条
  • [41] PERIODIC DEVELOPMENT OF NEUTRALIZING ANTIBODY-RESPONSES TO ANTIGENIC VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS
    QUINNAN, GV
    VUJCIC, L
    WELLS, M
    KATZENSTEIN, D
    VIAL, P
    LANE, HC
    CLINICAL RESEARCH, 1990, 38 (02): : A461 - A461
  • [42] HUMAN-IMMUNODEFICIENCY-VIRUS ANTIBODY-RESPONSES DETERMINED BY SITE-DIRECTED SEROLOGY
    NORRBY, E
    INTERVIROLOGY, 1990, 31 (06) : 315 - 326
  • [43] NATIVE OLIGOMERIC HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN ELICITS DIVERSE MONOCLONAL-ANTIBODY REACTIVITIES
    EARL, PL
    BRODER, CC
    LONG, D
    LEE, SA
    PETERSON, J
    CHAKRABARTI, S
    DOMS, RW
    MOSS, B
    JOURNAL OF VIROLOGY, 1994, 68 (05) : 3015 - 3026
  • [44] EXPRESSION OF ENVELOPE GLYCOPROTEINS OF HUMAN-IMMUNODEFICIENCY-VIRUS BY AN INSECT VIRUS VECTOR
    HU, SL
    KOSOWSKI, SG
    SCHAAF, KF
    JOURNAL OF VIROLOGY, 1987, 61 (11) : 3617 - 3620
  • [45] TRANSMISSION AND PATHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONNOR, RI
    HO, DD
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (04) : 321 - 323
  • [46] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION OF THE BRAIN
    ATWOOD, WJ
    BERGER, JR
    KADERMAN, R
    TORNATORE, CS
    MAJOR, EO
    CLINICAL MICROBIOLOGY REVIEWS, 1993, 6 (04) : 339 - 366
  • [47] PRODUCTION AND CHARACTERIZATION OF A MURINE MONOCLONAL-ANTIBODY AGAINST THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) ENVELOPE GLYCOPROTEIN GP120
    HULGAARD, EF
    BUGGE, T
    HOLMBACK, K
    HANSEN, LL
    KUSK, P
    LINDHARDT, BO
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 32 (04) : 397 - 397
  • [48] CELLULAR LATENCY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    POMERANTZ, RJ
    BAGASRA, O
    BALTIMORE, D
    CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (04) : 475 - 480
  • [49] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148
  • [50] HEADACHE AND THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    HOLLOWAY, RG
    KIEBURTZ, KD
    HEADACHE, 1995, 35 (05): : 245 - 255